Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 3
2008 3
2009 4
2013 2
2014 3
2015 3
2016 2
2017 2
2018 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Edoxaban for Cancer-Associated Venous Thromboembolism.
Nasser NJ. Nasser NJ. N Engl J Med. 2018 Jul 5;379(1):94-5. doi: 10.1056/NEJMc1806646. N Engl J Med. 2018. PMID: 29975033 No abstract available.
Potential Mechanisms of Cancer-Related Hypercoagulability.
Nasser NJ, Fox J, Agbarya A. Nasser NJ, et al. Cancers (Basel). 2020 Feb 29;12(3):566. doi: 10.3390/cancers12030566. Cancers (Basel). 2020. PMID: 32121387 Free PMC article. Review.
Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer.
Kundel Y, Nasser NJ, Rath-Wolfson L, Purim O, Yanichkin N, Brenner R, Zehavi T, Nardi Y, Fenig E, Sulkes A, Brenner B. Kundel Y, et al. Among authors: nasser nj. Am J Clin Oncol. 2018 Jun;41(6):613-618. doi: 10.1097/COC.0000000000000337. Am J Clin Oncol. 2018. PMID: 27740975
Heparanase involvement in physiology and disease.
Nasser NJ. Nasser NJ. Cell Mol Life Sci. 2008 Jun;65(11):1706-15. doi: 10.1007/s00018-008-7584-6. Cell Mol Life Sci. 2008. PMID: 18425416 Review.
Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy.
Thor M, Jackson A, Zelefsky MJ, Steineck G, Karlsdòttir A, Høyer M, Liu M, Nasser NJ, Petersen SE, Moiseenko V, Deasy JO. Thor M, et al. Among authors: nasser nj. Radiother Oncol. 2018 Apr;127(1):88-95. doi: 10.1016/j.radonc.2018.02.020. Epub 2018 Mar 9. Radiother Oncol. 2018. PMID: 29530433 Free PMC article.
Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients.
Nasser NJ, Fenig S, Ravid A, Nouriel A, Ozery N, Gardyn S, Koren R, Fenig E. Nasser NJ, et al. NPJ Breast Cancer. 2017 Mar 31;3:10. doi: 10.1038/s41523-017-0006-x. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 28649650 Free PMC article.
Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.
Nasser NJ, Thoms J, Soosaipillai A, Pintilie M, Wang R, Diamandis EP, Bristow RG. Nasser NJ, et al. Radiother Oncol. 2017 Sep;124(3):427-432. doi: 10.1016/j.radonc.2017.03.023. Epub 2017 Apr 17. Radiother Oncol. 2017. PMID: 28427756
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.
King MT, Nasser NJ, Mathur N, Cohen GN, Kollmeier MA, Yuen J, Vargas HA, Pei X, Yamada Y, Zakian KL, Zaider M, Zelefsky MJ. King MT, et al. Among authors: nasser nj. Brachytherapy. 2016 May-Jun;15(3):266-273. doi: 10.1016/j.brachy.2016.02.003. Epub 2016 Apr 20. Brachytherapy. 2016. PMID: 27009848 Free PMC article.
Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.
Nasser NJ, Cohen GN, Dauer LT, Zelefsky MJ. Nasser NJ, et al. Brachytherapy. 2016 Jul-Aug;15(4):420-425. doi: 10.1016/j.brachy.2016.03.012. Epub 2016 May 12. Brachytherapy. 2016. PMID: 27180125 Free PMC article.
Heparanase patents: dim past and bright future.
Nasser NJ, Nevo E. Nasser NJ, et al. Recent Pat Inflamm Allergy Drug Discov. 2013 May;7(2):162-7. doi: 10.2174/1872213x11307020007. Recent Pat Inflamm Allergy Drug Discov. 2013. PMID: 23537141
30 results
Jump to page